News / November 14, 2023
Daniel Bregman joins Synonym as General Counsel and Head of Development
Daniel joins the NYC-based biomanufacturing startup from Impossible Foods.
New York, NY - 14th November 2023 - Synonym, the New York-based biomanufacturing firm developing and funding the essential infrastructure for the biorevolution, today announces the appointment of Daniel Bregman as its General Counsel (GC) and Head of Development.
Daniel joins Synonym from Impossible Foods, one of the key firms in the alternative protein industry. Daniel spearheaded several key initiatives across the organization at Impossible and has built a wealth of experience in scaling clean technology startups. Prior to Impossible, Daniel held senior roles at vertical farming startup Plenty, as well as Cypress Creek Renewables, where he worked on dozens of clean energy projects.
Daniel began his career as a corporate lawyer at major international firm Cleary Gottlieb Steen & Hamilton. Daniel studied Political Science at the University of Pennsylvania and holds a Doctorate in Law (JD) from Columbia University.
In addition to his responsibilities as Synonym’s General Counsel, Daniel will also take up the role of Head of Development where he will push forward Synonym’s various projects already in pre-development. Daniel’s will be focused on driving successful expansion of Synonym’s development engine and accelerating the development cycles of facilities.
Edward Shenderovich, Co-Founder and Chief Executive Officer, commented: “For Synonym to accelerate the materials transition - and to help the bioeconomy reach its full economic and climate-impact potential - we need the best people who understand the opportunity in the still nascent synbio industry. We’re thrilled to have Daniel onboard to drive our growth, and to scale our legal and development teams in the coming months and years.”
Daniel Bregman, General Counsel and Head of Development, commented: “I look forward to working closely with the team in this exciting new hybrid role. I’m excited to dive headfirst into helping Synonym identify, purchase, and build its first infrastructure sites, and being a part of the coming biomanufacturing revolution”.
Synonym enables the commercialization and manufacture of bioproducts—accelerating the world’s transition to better, more sustainable materials and products. It believes that products created using biology will represent the next manufacturing revolution, transforming crucial elements of supply chains across multiple sectors and helping to catalyze a decarbonized future. Synonym works as the strategic biomanufacturing partner for companies building these next-generation bioproducts, helping them to expand and scale seamlessly. It has launched two online tools to help companies on their paths toward commercialization as the first step in their scaling journey: